Added to YB: 2026-02-03
Pitch date: 2026-01-31
EW [neutral]
Edwards Lifesciences Corporation
-3.09%
current return
Author Info
D Invests is a self taught investor with a focus on quality and value. This newsletter focuses on businesses within their portfolio past and present. Their aim is to double their investments every 5 years resulting in a target 15% CAGR. Sign up for the newsletter.
Company Info
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally.
Market Cap
$44.0B
Pitch Price
$81.44
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.86
P/E
41.92
EV/Sales
6.74
Sector
Health Care Equipment and Supplies
Category
N/A
D Invests | Portfolio Update January 2026 - Edwards Lifesciences Corporation
EW (exited position): Largest moated business w/ unmatched heart valve data & research track record, becoming industry norm for structural heart disease treatment. High quality with vital products but now fully valued - future gains likely mirror EPS growth. Thesis intact, on watchlist for re-entry on weakness.
Read full article (1 min)